Skip to main content
Home > About Us > Writers

Editorial & Research Team

› Senior Editors

Karen Bernstein, Ph.D., Co-Founder, Chairman & Editor-in-Chief
Karen has been writing and publishing on biotechnology since 1987. She holds a Ph.D. in political science from Stanford University and a B.A. in politics and history from Brandeis University, where she now is a member of the Brandeis University Science Advisory Council. She also is on the board of trustees of the Keck Graduate Institute of the Applied Life Sciences. In 2005, the annual gathering of biotechnology chief executive officers at The Biotech Meeting in Laguna Niguel, Calif., inducted Karen into their Hall of Fame, citing her lifetime contribution to the biotech community. In 2007, Karen received a Special Recognition award at the American Liver Foundation's Salute to Excellence, honoring individuals who have made an outstanding contribution to biotechnology and medical innovation. In 2013, Karen was named one of Silicon Valley Business Journal's 100 most influential women.
 
Jeff Cranmer, Managing Editor, BioCentury, the Bernstein Report on BioBusiness
Jeff serves as Managing Editor of BioCentury, the Bernstein Report on BioBusiness. Since joining BioCentury in 2005, Jeff has also been Editor of BioCentury Extra and head of BioCentury's Research Group. Jeff has an A.B. from Princeton University and an M.A. from the Johns Hopkins School of Advanced International Studies.
 
Simone Fishburn, Ph.D., Executive Editor, SciBX
Simone serves as BioCentury's Executive Editor in the SciBX joint publishing venture with Nature Publishing Group. Prior to joining BioCentury in 2013, Simone worked as a translational scientist in the biotech industry, including nine years in preclinical drug development at Nektar Therapeutics. Simone holds a Ph.D. in molecular pharmacology from the Weizmann Institute of Science in Israel, and an M.A. and B.A. in pharmacology from Cambridge University.
 
Erin McCallister, Senior Editor
Erin joined BioCentury in 2008. She previously was a program officer at The Great Lakes Protection Fund and a biologist at Dow AgroSciences LLC. She holds an M.Sc. in environmental science and policy from the University of Chicago and a B.S. in biology from Purdue University.
 
Susan Schaeffer, Editor, BioCentury, the Bernstein Report on BioBusiness
Susan serves as Editor of BioCentury, the Bernstein Report on BioBusiness. She was previously Senior Editor in charge of Product Discovery & Development coverage from 2010 through 2012. She was Managing Editor of BioCentury, the Bernstein Report on BioBusiness, and BioCentury Extra from 2004 through 2010. She joined BioCentury in 2003 after 10 years as an editor in the consumer packaged goods sector, including work with international strategy consultants Kurt Salmon Associates.
 
Steve Usdin, Senior Editor, Washington
Steve has been Washington Editor of BioCentury since 1993, and has spent the past 20 years in the nation's capital covering political and policy issues affecting the life sciences sector. He also is the host of BioCentury This Week, BioCentury's weekly public affairs television program, as well as BioCentury Senior Editor responsible for coverage of social issues involving biotechnology. Steve’s reporting about biotechnology and biomedical policy has been cited in The Economist, The Wall Street Journal, the Washington Post, New Scientist and other publications. In 2012, the FDA Alumni Association named Steve the Harvey W. Wiley Lecturer, making him the first journalist to receive the Wiley Award. His book, “Engineering Communism: How Two Americans Spied for Stalin and Founded the Soviet Silicon Valley,” was published in 2005 by Yale University Press.
 
Walter Yang, Director of Research
Walter, who directs BioCentury's editorial research effort, has been a Staff Writer and Research Analyst since joining the company in 1999. Walter previously worked as a researcher at the Salk Institute for Biological Studies. He holds a B.S. in molecular biology from the University of California, San Diego, and has a master's degree in accounting and finance from the London School of Economics and Political Science.
 

› Senior Writers

Chris Cain, Ph.D., Senior Writer
Chris joined BioCentury in 2010 after completing his Ph.D. in biochemistry and molecular biology at the University of California, San Francisco, where he used whole-genome approaches to investigate how transcriptional regulatory networks evolve. He holds a B.A. in biology from the College of Creative Studies at UC Santa Barbara, where he studied mechanisms of bacterial pathogenesis.
 
Emily Cukier-Meisner, Senior Writer
Emily joined BioCentury in 2013 after gaining over six years of experience in the analysis and classification of clinical-stage drug products at Brand Institute. Previously, she conducted studies of protein folding at the University of Chicago and University of Cincinnati. She holds a B.S. in chemistry from Harvey Mudd College and an M.S. from the University of Chicago in biochemistry and molecular biology.
 
Michael Flanagan, Senior Writer
Michael has been a writer and news editor at BioCentury since 2004. Prior to earning a B.S. in medical biology at Beloit College, Michael held internships at labs associated with the Wisconsin Department of Agriculture, Trade and Consumer Protection; the University of Wisconsin Department of Animal Sciences; and the University of Wisconsin Psychiatric Institute and Clinics.
 
Michael J. Haas, Senior Writer
Mike joined BioCentury in 2007 after gaining nearly 14 years of experience as an analytical chemist and mass spectrometry group leader at DuPont, DuPont Merck, DuPont Pharma and Bristol-Myers Squibb. He holds an M.Sc. in chemistry from the University of Toronto and a B.S. in chemistry from the University of Delaware.
 
Stephen Hansen, Senior Writer
Stephen has been a writer and news editor for BioCentury since 2006. He holds B.A.s in biology and history from Bethel University and an M.Phil in history from Oxford University.
 
Kai-Jye Lou, Senior Writer
Kai-Jye joined BioCentury in 2008 after completing a M.S. in biomedical engineering and B.S. in computational and systems biology at the University of California, Los Angeles. His past research projects have included developing control algorithms for stabilizing cardiac arrhythmias and building pharmacokinetic and pharmacodynamic models.